Huadong Medicine debuts with $150m loan

Covid_lab_575px_Adobe_8June20
By Pan Yue
02 Mar 2021

China’s Huadong Medicine Co has turned to the loan market for the first time.

Standard Chartered is the sole mandated lead arranger and bookrunner for the $150m facility, according to a banker who received the invitation.

The loan has a tenor of three years, and amortises over 2.7 years. The margin is set at 115bp over Libor. Mandated lead arrangers committing ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial